Helicobacter pylori in the 21st Century
Will be published approx. on 22. June 2010
Book
Hardback
320 pages
978-1-84593-594-8 (ISBN)
Description
Helicobacter pylori is a globally significant pathogen that infects half of the population of the world. Its recognition enabled the development of new therapeutic and preventative strategies for serious health conditions such as gastric cancer, of which it is the major causative agent. Providing a broad overview of the current understanding of this pathogen and emphasising its world health impacts, this book explores a range of topics including virulence factors, vaccine development and obstacles, epidemiology, antibiotic resistance and the role of Nod receptors, with a foreword by Barry Marshall, the Nobel Laureate and co-discoverer of H. pylori. It is an essential resource for researchers, students and medics in infectious and Helicobacter-associated diseases.
More details
Series
Language
English
Place of publication
Wallingford
United Kingdom
Target group
College/higher education
Professional and scholarly
Product notice
sewn/stitched
Cloth over boards
Dimensions
Height: 246 mm
Width: 175 mm
Thickness: 23 mm
Weight
885 gr
ISBN-13
978-1-84593-594-8 (9781845935948)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Editor
University of Melbourne, Australia
University of New South Wales, Australia
Contributions
University College Dublin, Ireland
Institute of Microbiology and Hygiene, Gastrointestinal Microbiology Research Group, Charite-University Medicine, Dorotheenstr. 96, D-12203 Berlin, , GERMANY
Department of Pediatrics, School of Medicine, University of Maryland, 655 W. Baltimore Street, Baltimore, MD 21201, UNITED STATES
Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University, 2215 Garland Ave., 1030 MRB IV, Nashville, TN 37232-0252, UNITED STATES
Department of Microbiology, Monash University, Building 53, Wellington Road, Clayton, , Vic 3800, AUSTRALIA
Division of Gastroenterology, Department of Medicine, New Changi Hospital, 2 Simei Street 3, , 529889, SINGAPORE
Goethenburg University, Sweden
Veterans Affair Medical Center 111D, 2002 Holcombe Blvd., Houston, , Texas, TX 77030, UNITED STATES
Content
I: PATHOLOGIES AND TREATMENT 1: Epidemiology of Helicobacter pylori infection - Hoda Malaty 2: Helicobacter pylori infection in Asia - Kwong Fock 3: Gastric adenocarcinoma - Pelayo Correa and M. Blanca Piazuelo 4: Antimicrobial resistance and approaches to treatment - Francis Megraud 5: Extragastric manifestations of Helicobacter pylori infection - Hazel Mitchell, Nadeem Kaakoush and Philip Sutton II: HOST RESPONSE 6: Helicobacter pylori-induced acquired immunity and immunoregulation - Karen Robinson and John C Atherton 7: Host genetic factors and susceptibility to Helicobacter pylori pathogenesis - Philip Sutton, Alison L Every and Stacey N Harbour 8: Innate immune initiators and effectors in H. pylori infection - Maria Kaparakis, Cody C. Allison, Melanie L. Hutton and Richard L. Ferrero 9: Helicobacter pylori vaccines - Thomas Blanchard and John G Nedrud III: BACTERIAL DEFENCE 10: Lipopolysaccharides of Helicobacter pylori: importance in gastric adaptation and pathogenesis - Anthony P Moran 11: Virulence factors of Helicobacter pylori - Steffen Backert, Hitomi Mimuro, Dawn A Israel and Richard M Peek, Jr. 12: Helicobacter pylori adhesion to the gastric surface - Sara K Linden, Anna Arnqvist, Susanne Teneberg and Anthony P. Moran 13: Helicobacteromics - Hilde de Reuse, Markus M Heimesaat and Stefan Bereswill